Elder Pharmaceuticals has reported a consolidated total income from operations of Rs 152.06 crore and a net loss of Rs 46.02 crore for the quarter ended Mar '15
Elder Pharmaceuticals has reported a consolidated total income from operations of Rs 157.93 crore and a net loss of Rs 83.56 crore for the quarter ended Dec '14
Elder Pharmaceuticals has reported a consolidated total income from operations of Rs 203.14 crore and a net loss of Rs 46.87 crore for the quarter ended Sep '14
Elder Pharmaceuticals has reported a sales turnover of Rs 387.07 crore and a net loss of Rs 23.34 crore for the quarter ended Dec '13
Elder Pharma's anti-infectives division has been contributing more than 10 percent to the total revenue and has been registering annual growth of more than 12 percent.
According to Habil F Khorakiwala, India is becoming a research and manufacturing hub for global pharmaceutical generic companies and the Indian companies that have well established base in the generic space like Stride transaction are getting high valuation.
The pharmaceutical space has been buzzing and the Torrent Pharmaceuticals-Elder Pharmaceuticals‘ deal remains in focus. CNBC-TV18‘s Ekta Batra gives more details on the acquisition.
Analysts pointed out that post payment of debt and taxes, Elder would only be left with cash of about Rs 400 crore and peripheral businesses that are not as profitable as the one it has sold.
Elder Pharmaceuticals said its board of directors with a view to reducing the debt of the company had approved the proposal for carrying out restructuring of business involving either raising of capital, hiving off of assets or other strategic Options and had decided to appoint advisors for this purpose.
Elder Pharmaceuticals has reported a sales turnover of Rs 272.76 crore and a net profit of Rs 3.14 crore for the quarter ended Sep '13
Rajshree Sugars | 3M India | GTL Infra | Future Retail | Kalpataru Power | Magma Fincorp | Glenmark Pharma | Dishman Pharma | Sesa Sterlite | IDFC | Tata Motors | HCL Technologies | SpiceJet | Religare Enterprises | IOC | MCX | Jagaran Prakashan and Elder Pharma are stocks, which are in the news today.
Wockhardt | Cairn India | IOC | Bosch | TTK Prestige | MCX | Wipro | HCL Technologies | Financial Technologies | Jet Airways | Tech Mahindra | Jaiprakash Power | JSW Steel and JSW Energy are stocks, which are in the news today.
Saurabh Mittal of Swadeshi Credits advises buying Dena Bank with a target price of Rs 52 and Rolta with a target price of Rs 61.
Here's how small cap stocks opened on September 13
Here's how small cap stocks opened on September 6
Vishal Malkan of malkansview.com advised buying Opto Circuits for a target price of Rs 27.50 and Titan Industries for a target price of Rs 240.
The drug company's sales was down around 50 percent to Rs 184 crore. During the period, its profit too shrunk to Rs 84.3 lakh compared to Rs 18 crore on lower sales and a higher finance cost.
MphasiS | Rolta India | Elder Pharma | Financial Technologies | Hexaware Technologies | Jayant Agro Organics | Jindal Steel & Power | Shriram EPC and Coal India are stocks, which are in the news today.
Here is how small cap stocks open on August 29
Infosys | Bharti Airtel | Mphasis | Shree Renuka Sugars | Elder Pharma | Container Corporation | JK Paper and Pioneer Distilleries are stocks, which are in the news today.
ITC | Maruti Suzuki | ACC | Ambuja Cements | Elder Pharma | Wockhardt | Diamond Power | Hero MotoCorp | Cairn India | Novartis India and Central Bank of India are stocks, which are in the news today.
Mangalore Chemicals | Elder Pharma | Wockhardt | Apollo Tyres | HPCL | HDIL and KEI Industries and Infosys are stocks, which are in the news today.
All eyes will be on Narayan Murthy's return and commentary from him as earnings season officially kicks starts with IT major Infosys reporting April-June numbers today.
Elder Pharma | Sadbhav Engineering | Unitech | Oil India | IOC | Tata Power | Jet Airways | Tata Motors | Hero MotoCorp and Ashok Leyland are stocks, which are in the news today.
The stock hit 5 percent upper circuit limit on Wednesday following a report that companies like Sanofi Aventis, Novartis and GlaxoSmithKline were in the race to buy out the company's domestic formulations business.